For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.
Adverse Events Module path is as follows:
Study -> Results Section -> Adverse Events Module -> Event Groups
Study -> Results Section -> Adverse Events Module -> Serious Events
Study -> Results Section -> Adverse Events Module -> Other Events
| Title | Description | Deaths # Affected | Deaths # At Risk | Serious # Affected | Serious # At Risk | Other # Affected | Other # At Risk | View |
|---|---|---|---|---|---|---|---|---|
| Not Assigned | One participant was assigned to receive intermittent cobimetinib 80 milligrams (mg) + GDC 0994 200 mg) and did receive study drug. However, the participant diary was not returned, and the site was unable to document study dose administration. | None | None | 1 | 1 | 1 | 1 | View |
| COB 20 mg + GDC 200 mg | Concurrent or intermittent dosing of cobimetinib 20 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off. | None | None | 2 | 5 | 5 | 5 | View |
| COB 40 mg + GDC 200 mg | Concurrent or intermittent dosing of cobimetinib 40 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off. | None | None | 2 | 3 | 3 | 3 | View |
| COB 80 mg + GDC 200 mg | Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off. | None | None | 3 | 5 | 5 | 5 | View |
| COB 80 mg + GDC 400 mg | Concurrent or intermittent dosing of cobimetinib 80 mg, concurrent with GDC-0994 400 mg for 21 consecutive days, followed by 7 days off. | None | None | 2 | 4 | 4 | 4 | View |
| COB 100 mg + GDC 200 mg | Concurrent or intermittent dosing of cobimetinib 100 mg, concurrent with GDC-0994 200 mg for 21 consecutive days, followed by 7 days off. | None | None | 4 | 6 | 6 | 6 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| DIARRHOEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| ABDOMINAL PAIN | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| COLITIS | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| CONSTIPATION | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| DYSPHAGIA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| GASTRIC ULCER | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| GASTROINTESTINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| NAUSEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| CHOLANGITIS INFECTIVE | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| CLOSTRIDIUM DIFFICILE COLITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| KLEBSIELLA BACTERAEMIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| PNEUMONIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| PNEUMONIA VIRAL | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| DISEASE PROGRESSION | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| GAIT DISTURBANCE | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| OEDEMA PERIPHERAL | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| PYREXIA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| DYSPNOEA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| HYPOXIA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| PULMONARY EMBOLISM | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| ANAEMIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 19.1 | View |
| MYOCARDIAL INFARCTION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| DEHYDRATION | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| Term | Type | Organ System | Vocab | View |
|---|---|---|---|---|
| ANAEMIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 19.1 | View |
| THROMBOCYTOPENIA | SYSTEMATIC_ASSESSMENT | Blood and lymphatic system disorders | 19.1 | View |
| ACUTE MYOCARDIAL INFARCTION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| ABDOMINAL PAIN UPPER | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| ASCITES | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| COLITIS | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| CONSTIPATION | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| DIARRHOEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| DRY MOUTH | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| DYSPEPSIA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| FLATULENCE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| GASTROINTESTINAL HAEMORRHAGE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| GASTROOESOPHAGEAL REFLUX DISEASE | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| HAEMATOCHEZIA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| NAUSEA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| SALIVARY GLAND ENLARGEMENT | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| VOMITING | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| ASTHENIA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| CHILLS | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| FACE OEDEMA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| GENERALISED OEDEMA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| LOCALISED OEDEMA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| NON-CARDIAC CHEST PAIN | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| OEDEMA PERIPHERAL | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| PERIPHERAL SWELLING | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| PYREXIA | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| ATYPICAL PNEUMONIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| BRONCHITIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| PNEUMONIA | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| SEPSIS | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| UPPER RESPIRATORY TRACT INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| VULVOVAGINAL MYCOTIC INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| CONTUSION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 19.1 | View |
| LACERATION | SYSTEMATIC_ASSESSMENT | Injury, poisoning and procedural complications | 19.1 | View |
| ALANINE AMINOTRANSFERASE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| BLOOD ALBUMIN DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| BLOOD ALKALINE PHOSPHATASE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| BLOOD BILIRUBIN INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| BLOOD LACTATE DEHYDROGENASE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| EJECTION FRACTION DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| GAMMA-GLUTAMYLTRANSFERASE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| PLATELET COUNT DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| PROTEIN TOTAL DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| TROPONIN INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| WEIGHT DECREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| WHITE BLOOD CELL COUNT INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| DECREASED APPETITE | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| DEHYDRATION | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPERKALAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOALBUMINAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOCALCAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOGLYCAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOKALAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOMAGNESAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOPHOSPHATAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| HYPOVOLAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| MALNUTRITION | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| ARTHRALGIA | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| BACK PAIN | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| MUSCLE SPASMS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| MUSCULAR WEAKNESS | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| MYALGIA | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| PAIN IN EXTREMITY | SYSTEMATIC_ASSESSMENT | Musculoskeletal and connective tissue disorders | 19.1 | View |
| ATAXIA | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| BURNING SENSATION | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| DIZZINESS | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| HEADACHE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| HYPOAESTHESIA | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| LETHARGY | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| PRESYNCOPE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| VISUAL FIELD DEFECT | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| CONFUSIONAL STATE | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 19.1 | View |
| DELIRIUM | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 19.1 | View |
| INSOMNIA | SYSTEMATIC_ASSESSMENT | Psychiatric disorders | 19.1 | View |
| ACUTE KIDNEY INJURY | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 19.1 | View |
| DYSURIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 19.1 | View |
| HAEMATURIA | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 19.1 | View |
| URINARY RETENTION | SYSTEMATIC_ASSESSMENT | Renal and urinary disorders | 19.1 | View |
| ALVEOLAR LUNG DISEASE | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| COUGH | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| DYSPHONIA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| DYSPNOEA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| EPISTAXIS | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| PLEURAL EFFUSION | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| PNEUMONITIS | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| PULMONARY HYPERTENSION | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| PULMONARY OEDEMA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| RHINORRHOEA | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| SINUS CONGESTION | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| TONSILLAR HYPERTROPHY | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| ALOPECIA | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| DERMATITIS ACNEIFORM | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| DRY SKIN | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| HYPERHIDROSIS | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| NIGHT SWEATS | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| PAIN OF SKIN | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| RASH | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| RASH MACULAR | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| RASH MACULO-PAPULAR | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| RASH PRURITIC | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| SWELLING FACE | SYSTEMATIC_ASSESSMENT | Skin and subcutaneous tissue disorders | 19.1 | View |
| BLOOD LACTIC ACID INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| BLOOD UREA INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |
| HYPONATRAEMIA | SYSTEMATIC_ASSESSMENT | Metabolism and nutrition disorders | 19.1 | View |
| SOMNOLENCE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| SYNCOPE | SYSTEMATIC_ASSESSMENT | Nervous system disorders | 19.1 | View |
| PULMONARY EMBOLISM | SYSTEMATIC_ASSESSMENT | Respiratory, thoracic and mediastinal disorders | 19.1 | View |
| DEEP VEIN THROMBOSIS | SYSTEMATIC_ASSESSMENT | Vascular disorders | 19.1 | View |
| HYPOTENSION | SYSTEMATIC_ASSESSMENT | Vascular disorders | 19.1 | View |
| THROMBOSIS | SYSTEMATIC_ASSESSMENT | Vascular disorders | 19.1 | View |
| LEFT VENTRICULAR DYSFUNCTION | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| SINUS BRADYCARDIA | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| SINUS TACHYCARDIA | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| TACHYCARDIA | SYSTEMATIC_ASSESSMENT | Cardiac disorders | 19.1 | View |
| DYSACUSIS | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 19.1 | View |
| VERTIGO | SYSTEMATIC_ASSESSMENT | Ear and labyrinth disorders | 19.1 | View |
| ADRENAL INSUFFICIENCY | SYSTEMATIC_ASSESSMENT | Endocrine disorders | 19.1 | View |
| DETACHMENT OF RETINAL PIGMENT EPITHELIUM | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| EYELID OEDEMA | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| PERIORBITAL OEDEMA | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| PHOTOPHOBIA | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| VISION BLURRED | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| VISUAL IMPAIRMENT | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| VITREOUS FLOATERS | SYSTEMATIC_ASSESSMENT | Eye disorders | 19.1 | View |
| ABDOMINAL DISTENSION | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| ABDOMINAL PAIN | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| ABDOMINAL PAIN LOWER | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| DYSPHAGIA | SYSTEMATIC_ASSESSMENT | Gastrointestinal disorders | 19.1 | View |
| FATIGUE | SYSTEMATIC_ASSESSMENT | General disorders | 19.1 | View |
| CANDIDA INFECTION | SYSTEMATIC_ASSESSMENT | Infections and infestations | 19.1 | View |
| ASPARTATE AMINOTRANSFERASE INCREASED | SYSTEMATIC_ASSESSMENT | Investigations | 19.1 | View |